Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL308634 | 0.83 | TSHR (0.41) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL2887866 | 0.82 | HTT (0.35) | LMNATSHRALDH1A1HTT | |
| SCHEMBL25858052 | 0.81 | HTT (0.43) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL27220786 | 0.81 | TSHR (0.41) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL2536484 | 0.79 | POLB (0.43) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL2536347 | 0.79 | GAA (0.50) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL25981449 | 0.79 | POLB (0.43) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL4397557 | 0.79 | TSHR (0.40) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL13280672 | 0.79 | TSHR (0.40) | LMNAPOLBTSHRGAATDP1 | |
| SCHEMBL27903554 | 0.79 | LMNA (0.41) | LMNAPOLBTSHRGAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025131951-A1 | LITHIUM SECONDARY BATTERY WITH HIGH ENERGY DENSITY AND SAFETY | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2025-06-26 | — | — | WO | claimed |
| US-20170187071-A1 | LITHIUM BATTERY ELECTROLYTE SOLUTION CONTAINING ETHYL (2,2,3,3-TETRAFLUOROPROPYL) CARBONATE | DOW GLOBAL TECHNOLOGIES LLC | 2017-06-29 | — | — | US | claimed |
| US-20170187062-A1 | LITHIUM BATTERY ELECTROLYTE SOLUTION CONTAINING METHYL (2,2,3,3,-TETRAFLUOROPROPYL) CARBONATE | DOW GLOBAL TECHNOLOGIES LLC | 2017-06-29 | — | — | US | claimed |
| EP-4292708-B1 | METHOD FOR PRODUCING CARBONYL HALIDE | UNIV KOBE NAT UNIV CORP (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4292708-A1 | METHOD FOR PRODUCING CARBONYL HALIDE | National University Corporation Kobe University (JP) | 2023-12-20 | — | — | EP | disclosed |
| US-20230348279-A1 | METHOD FOR PRODUCING CARBONYL HALIDE | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2023-11-02 | — | — | US | disclosed |
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| WO-2023080052-A1 | POLYURETHANE PRODUCTION METHOD | 国立大学法人神戸大学 | 2023-05-11 | — | — | WO | disclosed |
| WO-2022172744-A1 | METHOD FOR PRODUCING CARBONYL HALIDE | 国立大学法人神戸大学 | 2022-08-18 | — | — | WO | disclosed |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2021-10-14 | — | — | US | disclosed |
| CN-110943253-A | High-voltage lithium ion battery combined electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2020-03-31 | — | — | CN | disclosed |
| WO-2015183597-A1 | LITHIUM BATTERY ELECTROLYTE SOLUTION CONTAINING ETHYL (2,2,3,3-TETRAFLUOROPROPYL) CARBONATE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183599-A1 | LITHIUM BATTERY ELECTROLYTE SOLUTION CONTAINING METHYL (2,2,3,3,-TETRAFLUOROPROPYL) CARBONATE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183599-A1 | LITHIUM BATTERY ELECTROLYTE SOLUTION CONTAINING METHYL (2,2,3,3,-TETRAFLUOROPROPYL) CARBONATE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-12-03 | — | — | WO | disclosed |
| US-8735005-B2 | Fluorinated cyclic carbonates and compositions thereof | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-27 | — | — | US | disclosed |
| US-8530099-B2 | Multifunctional sulfone/fluorinated ester solvents | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-10 | — | — | US | disclosed |
| US-20120323036-A1 | MULTIFUNCTIONAL SULFONE/FLUORINATED ESTER SOLVENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120141870-A1 | MULTIFUNCTIONAL SULFONE/FLUORINATED ESTER SOLVENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-07 | — | — | US | disclosed |
| US-8092942-B1 | Multifunctional sulfone/fluorinated ester solvents | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-01-10 | — | — | US | disclosed |
| US-20110244313-A1 | Fluorinated Cyclic Carbonates and Compositions Thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | LMNA 4578/4885POLB 4477/4885TSHR 2418/4885 |
| US-20120323036-A1 | MULTIFUNCTIONAL SULFONE/FLUORINATED ESTER SOLVENTS | PFAS, STS, SULT1E1 | LMNA 3529/4885POLB 4351/4885TSHR 2217/4885 |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | LMNA 4578/4885POLB 4477/4885TSHR 2418/4885 |
| US-20120141870-A1 | MULTIFUNCTIONAL SULFONE/FLUORINATED ESTER SOLVENTS | PFAS, STS, SULT1E1 | LMNA 3529/4885POLB 4351/4885TSHR 2217/4885 |
| US-20110244313-A1 | Fluorinated Cyclic Carbonates and Compositions Thereof | CA2, PFAS, CA7 | LMNA 1215/4885POLB 2704/4885TSHR 2987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.